Natco Pharma Limited has informed the Exchange regarding Appointment of Mr AMIT PAREKH as Other of the company w.e.f. December 02, 2025.
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma Limited has informed the stock exchange about the appointment of Mr. Amit Parekh as a Director in the 'Other' category (typically Non-Executive/Non-Independent category) with effect from December 2, 2025. The appointment will add to the company's board composition. No additional details about his role, tenure, or background were provided in this disclosure. The exact designation within 'Other Director' category (Non-Executive, Nominee, or other) is not clarified in the filing.
This is a routine board-level appointment disclosure. For shareholders, this does not materially change the business outlook but signals ongoing board composition changes. The stock price is unlikely to react significantly unless further context about the appointee's role or significance emerges.